Acceleron Pharma Inc Operating margin

What is the Operating margin of Acceleron Pharma Inc?

The Operating margin of Acceleron Pharma Inc is -226.57%

What is the definition of Operating margin?



Operating margin is the ratio of operating income divided by net sales and presented in percent.

ttm (trailing twelve months)

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Operating margin of companies in the Health Care sector on NASDAQ compared to Acceleron Pharma Inc

What does Acceleron Pharma Inc do?

Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.

Companies with operating margin similar to Acceleron Pharma Inc